The anti-inflammatory capacity of apoB-depleted plasma was impaired in the NAFLD patients [1.18 vs 0.2 fold increase in VCAM-1 mRNA expression; P < 0.001] (Fig 1A). Here, APOB is linked to metabolic dysfunction-associated steatotic liver disease.